Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$10.84 - $15.43 $108,400 - $154,300
10,000 New
10,000 $151,000
Q4 2020

Feb 16, 2021

SELL
$24.99 - $38.45 $7.65 Million - $11.8 Million
-306,225 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$29.04 - $37.49 $5.19 Million - $6.7 Million
-178,662 Reduced 36.85%
306,225 $10.1 Million
Q2 2020

Aug 14, 2020

SELL
$20.16 - $34.84 $664,453 - $1.15 Million
-32,959 Reduced 6.36%
484,887 $16.9 Million
Q1 2020

May 15, 2020

SELL
$16.59 - $34.94 $3.11 Million - $6.54 Million
-187,166 Reduced 26.55%
517,846 $12 Million
Q4 2019

Feb 14, 2020

BUY
$22.24 - $27.56 $7.97 Million - $9.88 Million
358,476 Added 103.45%
705,012 $17.7 Million
Q3 2019

Nov 14, 2019

SELL
$25.56 - $36.1 $889,360 - $1.26 Million
-34,795 Reduced 9.12%
346,536 $9.45 Million
Q2 2019

Aug 14, 2019

BUY
$24.79 - $32.96 $9.45 Million - $12.6 Million
381,331 New
381,331 $12.6 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Intrinsic Edge Capital Management LLC Portfolio

Follow Intrinsic Edge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.